Log In
BCIQ
Print this Print this
 

BF-Derm1

  Manage Alerts
Collapse Summary General Information
Company Biofrontera AG
DescriptionHistidine decarboxylase (HDAC) inhibitor
Molecular Target Histidine decarboxylase (HDC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationUrticaria
Indication DetailsTreat severe chronic urticaria
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today